Journal Image
Current Cancer Drug Targets
ISSN (Print): 1568-0096
ISSN (Online): 1873-5576
Quick Track
DOI: 10.2174/15680096113138880007      Price:  $95

Therapeutic Perspectives on Pancreatic Cancer

Author(s): Anjali V. Sheahan, Phoebe A. Phillips and Levon M. Khachigian
Pages 1-11 (11)
Pancreatic cancer has a poor prognosis, with only 10% survival one year following diagnosis. Despite significant advances in conventional therapies (chemotherapy and radiotherapy), little improvement in patient survival has occurred in the last decade. Therefore, there is a critical need for novel and effective therapeutic approaches for this cancer. This article reviews current concepts in the pathogenesis and treatment of pancreatic cancer, the latter including tumor resection approaches and the current standard of care. We further describe recent advances in new and combination therapies, which result only in modest increases in survival, and discuss challenges in drug delivery and limiting toxicity.
Pancreatic cancer, targeted therapy, side-effects, stroma, chemotherapy
Centre for Vascular Research, University of New South Wales, Sydney, NSW 2052 Australia